Oppenheimer assumes Tarsus Pharmaceuticals (TARS) at Outperform (correction)
Tweet Send to a Friend
(Updated - June 2, 2025 8:56 AM EDT)
Oppenheimer analyst Suraj Kalia assumes Tarsus Pharmaceuticals (NASDAQ: TARS) at Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Suraj Kalia assumes Tarsus Pharmaceuticals (NASDAQ: TARS) at Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
